ELL Antikörper (C-Term)
-
- Target Alle ELL Antikörper anzeigen
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Bindungsspezifität
- AA 523-553, C-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ELL Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody detects ELL at C-term.
- Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse
- Aufreinigung
- Purified through a protein A column; followed by peptide affinity purification.
- Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 523-553aa) of human ELL.
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product ELL Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS with 0.09 % (W/V) Sodium Azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- ELL (Elongation Factor RNA Polymerase II (ELL))
- Andere Bezeichnung
- ELL (ELL Produkte)
- Hintergrund
- Synonyms: C19orf17, Eleven-nineteen lysine-rich leukemia protein, RNA polymerase II elongation factor ELL
- Gen-ID
- 8178
- NCBI Accession
- NP_006523
-